Ayyoun is a staff writer who loves all things gaming and tech. His journey into the realm of gaming began with a PlayStation 1 but he chose PC as his platform of choice. With over 6 years of ...

Beginning Sept. 1, the European Union has banned an ingredient commonly found in gel nail polish. The banned substance, TPO (trimethylbenzoyl diphenylphosphine oxide), gives nails a super glossy sheen ...

Community driven content discussing all aspects of software development from DevOps to design patterns. The 1.0 version of the Hypertext Transfer Protocol, issued way back in 1996, only defined three ...

Cathie Wood’s ARK Invest has named Canada-based SOL Strategies as its exclusive staking partner for the company’s Digital Assets Revolutions Fund. Under the partnership, ARK Invest will move its ...

A research team affiliated with UNIST has made a significant breakthrough in sustainable technology through the development of a method to convert carbon dioxide (CO₂) into methanol—a process that ...

Sol Strategies’ stock price rose by more than 4% following the announcement that it has filed to be listed on the Nasdaq exchange. Sol Strategies, a Canadian firm that focuses on the Solana ecosystem, ...

Titanium Dioxide, a common additive found in more than 11,000 U.S. foods, has been linked to oxidative stress, organ damage, and even cancer. Stacey Leasca is an award-winning journalist with nearly ...

Methods to enhance the ocean's uptake of carbon dioxide (CO₂) are being explored to help tackle the climate crisis. However, some of these approaches could significantly exacerbate ocean deoxygenation ...

It's all well and good investing your hard-earned money into a swanky new set of gel nails (courtesy of your fave highstreet salon), but when it comes to the end of your manis' shelf-life, if you're ...

In recent years, soft gel nails have grown in popularity—so much so that even Tom Bachik, Jennifer Lopez’s go-to nail expert, relies on them to create the star’s natural-looking nails. If you’re a fan ...

Sol-Gel Technologies secures $16 million for clinical trials, advancing SGT-610 for Gorlin syndrome and extending cash runway to 2027. Sol-Gel Technologies, Ltd. has announced a product purchase ...